发状分裂相关增强子-5重组兔单抗

Rrmab®兔单抗
2026-01-04~2026-02-28,RR26012026-01-04~2026-02-28,TR
发状分裂相关增强子-5重组兔单抗
货号:bsm-60648R
产品详情
相关标记
相关产品
相关文献
常见问题

概述

产品编号
bsm-60648R
产品类型
重组兔单抗
英文名称
HES5 Recombinant Rabbit mAb
中文名称
发状分裂相关增强子-5重组兔单抗
英文别名
bHLHb38; HES5_HUMAN; HES5; Class B basic helix-loop-helix protein 38 (bHLHb38); Hairy and enhancer of split 5; HES5_MOUSE; Hes-5; HES5_RAT;
抗体来源
Rabbit
免疫原
A synthesized peptide derived from human HES5: 1-166/166
亚型
IgG
性状
Liquid
纯化方法
affinity purified by Protein A
克隆类型
Recombinant
克隆号
R4G8
理论分子量
18 kDa
浓度
1mg/ml
储存液
0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
SWISS
Gene ID
保存条件
Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
注意事项
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
背景资料
This gene encodes a member of a family of basic helix-loop-helix transcriptional repressors. The protein product of this gene, which is activated downstream of the Notch pathway, regulates cell differentiation in multiple tissues. Disruptions in the normal expression of this gene have been associated with developmental diseases and cancer. [provided by RefSeq, Dec 2008]
发状分裂相关增强子-5重组兔单抗发状分裂相关增强子-5重组兔单抗发状分裂相关增强子-5重组兔单抗发状分裂相关增强子-5重组兔单抗发状分裂相关增强子-5重组兔单抗发状分裂相关增强子-5重组兔单抗发状分裂相关增强子-5重组兔单抗发状分裂相关增强子-5重组兔单抗

产品应用

应用已检合格种属预测种属推荐稀释比例
WBHuman, Mouse, Rat1:500-2000
IHC-PHuman, Mouse, Rat1:100-500
IHC-FHuman, Mouse, Rat1:100-500
IFHuman, Mouse, Rat1:100-500

交叉反应

交叉反应: Human, Mouse, Rat

相关产品

暂无相关产品

靶标

基因名
HES5
蛋白名
Transcription factor HES-5
亚基
Transcription repression requires formation of a complex with a corepressor protein of the Groucho/TLE family.
亚细胞定位
Nucleus.
组织特异性
Expressed in fetal heart and brain tumors.
相似性
Contains 1 basic helix-loop-helix (bHLH) domain.
Contains 1 Orange domain.
功能
Transcriptional repressor of genes that require a bHLH protein for their transcription

标记抗体

暂无标记数据

同靶标产品

暂无同靶标产品

相关文献

提示: 发表研究结果有使用 bsm-60648R 时请让我们知道,以便我们可以引用参考文章。作为回馈,资料提供者将获得我们送上的小礼品。

暂无相关文献

常见问题

暂无常见问题